ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
New analyses support the effectiveness and safety of Entyvio (vedolizumab)
May 31, 2017Data showcased at Digestive Disease Week (DDW) 2017 meeting include presentations of new analyses from the VICTORY consortium. -
RedHill Biopharma Announces First Patient Dosed in the Open-Label Extension Study to the Phase III S
March 22, 2017A first randomized, double-blind, placebo-controlled Phase III clinical study with RHB-104 for the treatment of Crohn’s disease (the MAP US study) is ongoing in the U.S. and additional countries. -
Celltrion Healthcare’s biosimilar shows positive results in Crohn’s disease study
February 21, 2017Celltrion Healthcare presented the primary outcome from its pivotal randomised controlled trial of CT-P13 (biosimilar of infliximab) in Crohn’s disease. -
Enterome starts Phase I Crohn’s disease trial
January 06, 2017Enterome has launched a Phase I clinical study with its lead drug candidate EB8018, a small molecule designed to block FimH, as a potential new treatment for Crohn’s disease.
Pharma Sources Insight January 2025
